Weight-Loss drug semaglutide may leave stomach full despite fasting, study warns
NCT ID NCT06263595
First seen May 02, 2026 · Last updated May 13, 2026 · Updated 3 times
Summary
This study looked at whether people taking semaglutide (a GLP-1 drug for diabetes or weight loss) have more food or liquid left in their stomach before surgery, even after following fasting rules. Researchers used ultrasound to measure stomach contents in 94 patients. The goal was to gather data to help create safer anesthesia guidelines and reduce the risk of aspiration (stomach contents entering the lungs).
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ASPIRATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
South Health Campus
Calgary, Alberta, T3M 1M4, Canada
Conditions
Explore the condition pages connected to this study.